ASP ISOTOPES INC
ASPINASDAQTrading Snapshot
- Day Range
- $2.62 β $2.66
- 52-Week Range
- $2.51 β $14.49
- Volume
- $8.09B
- Avg Volume
- $7.21B
- Shares Outstanding
- 149.1M
- Next Earnings
- Nov 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $24M
- Last Q Revenue
- $5M
- P/E Ratio
- β
- P/S Ratio
- 13.1x
- EPS (TTM)
- $-1.23
- Dividend Yield
- β
- Dilution (1yr)
- +32.5%
Why Investors Own ASPI
- βHigh-growth profile β revenue up +9.1% YoY with expanding US Equity exposure.
- βHealthy economics β 61% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ASP ISOTOPES INC
ASPIAbout ASP ISOTOPES INC
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 28, 2026Shareholders are encouraged to contact the firm

ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript
ASP Isotopes Inc. (ASPI) Analyst/Investor Day Transcript

ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update
DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for critical materials product

BlackRock Inc. Purchases Shares of 9,217,198 ASP Isotopes Inc. $ASPI
BlackRock Inc. acquired a new stake in shares of ASP Isotopes Inc. (NASDAQ: ASPI) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 9,217,198 shares of the company'

ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth
ASP Isotopes NASDAQ: ASPI expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied

ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa
Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has started the commissioning phase of the Phase 1 Liquid Helium plant post engineering optimization The production is expected to be among